AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PMV Pharmaceuticals, Inc. Director's Dealing 2023

Jun 12, 2023

34350_dirs_2023-06-12_4873d760-a663-433e-9086-acd1613d3a70.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2023-06-08

Reporting Person: Gallagher Carol Giltner (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-08	Stock Option (right to buy)	$5.59	A	21500	Acquired	2033-06-07	Common Stock (21500)	Direct
2023-06-08	Stock Option (right to buy)	$5.59	G	21500	Disposed	2033-06-07	Common Stock (21500)	Direct
2023-06-08	Stock Option (right to buy)	$5.59	G	21500	Acquired	2033-06-07	Common Stock (21500)	Indirect

Footnotes

F1: Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders.

F2: The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee.